ClinicalTrials.Veeva

Menu

International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia

Otsuka logo

Otsuka

Status and phase

Completed
Phase 3

Conditions

Hyponatremia

Treatments

Drug: Tolvaptan

Study type

Interventional

Funder types

Industry

Identifiers

NCT02449044
156-03-244

Details and patient eligibility

About

This study will assess the safety of long-term tolvaptan use in patients previously enrolled in shorter-term Phase 3 studies and gather information on the natural history of hyponatremia in the context of tolvaptan therapy and underlying disease states.

Enrollment

111 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age greater than or equal to 18 years.
  2. Ability to provide informed consent or assent.
  3. Prior successful participation in a tolvaptan hyponatremia trial termination with evidence of continued need or desire for therapy.

Exclusion criteria

  • A current medical condition where long-term treatment with an aquaretic agent may present an undue risk to the patient.
  • Hyponatremia which is acute, reversible, artifactual or due to conditions not associated with vasopressin excess or likely to respond to aquaretic therapy.
  • Hyponatremia due to reversible medical condition or therapy
  • Conditions associated with an independent imminent risk of morbidity and mortality
  • Conditions which confound the assessment of endpoints.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

111 participants in 1 patient group

Tolvaptan
Experimental group
Description:
Enrolled subjects began treatment with 15 mg tolvaptan QD. A titration between target doses of 15 mg, 30 mg, or 60 mg of trial medication was based on the subject's change in serum sodium concentration and clinical tolerance of the trial medication.
Treatment:
Drug: Tolvaptan

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems